These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21344720)

  • 1. Former drug execs lose appeal. Bid for re-entry to Medicare is denied.
    Rhea S
    Mod Healthc; 2010 Dec 20-27; 40(51):14. PubMed ID: 21344720
    [No Abstract]   [Full Text] [Related]  

  • 2. US drug companies paid $15bn in fines for fraudulent marketing in past five years.
    Tanne JH
    BMJ; 2010 Dec; 341():c7360. PubMed ID: 21177361
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug lawsuits building. Merck, Pfizer facing charges of misrepresentation.
    Benko LB
    Mod Healthc; 2006 Apr; 36(15):16. PubMed ID: 16669517
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent case developments in health law. False Claims Act: the right treatment for off-label marketing?
    Wang S
    J Law Med Ethics; 2010; 38(3):708-13. PubMed ID: 20880253
    [No Abstract]   [Full Text] [Related]  

  • 5. Disease management and antikickback regulations.
    Kozma CM
    Manag Care Interface; 2003 Dec; 16(12):34-5. PubMed ID: 14750462
    [No Abstract]   [Full Text] [Related]  

  • 6. Medicare and Medicaid fraud and abuse--initiatives on the horizon.
    Freeman J
    Iowa Med; 2007; 97(1):10. PubMed ID: 17444299
    [No Abstract]   [Full Text] [Related]  

  • 7. The home health industry faces mounting allegations of fraud.
    Sarraille WA
    J Long Term Home Health Care; 1998; 17(3):10-8. PubMed ID: 10182685
    [No Abstract]   [Full Text] [Related]  

  • 8. Medicare and state health care programs; fraud and abuse: OIG civil money penalties under the Medicare prescription drug discount card program. Final rule.
    Office of Inspector General (OIG), HHS
    Fed Regist; 2004 Dec; 69(239):74451-3. PubMed ID: 15597491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enforcement actions involving Medicaid fraud and abuse, 1996-2009.
    Qureshi ZP; Liu Y; Sartor O; Chu YH; Bennett CL
    Arch Intern Med; 2011 Apr; 171(8):785-7. PubMed ID: 21518950
    [No Abstract]   [Full Text] [Related]  

  • 10. Punishing health care fraud--is the GSK settlement sufficient?
    Outterson K
    N Engl J Med; 2012 Sep; 367(12):1082-5. PubMed ID: 22970920
    [No Abstract]   [Full Text] [Related]  

  • 11. Johnson & Johnson to pay $2.2bn to settle charges of false marketing on three drugs.
    Kmietowicz Z
    BMJ; 2013 Nov; 347():f6696. PubMed ID: 24196512
    [No Abstract]   [Full Text] [Related]  

  • 12. HCFA to investigate FHP's marketing to seniors.
    Kenkel PJ
    Mod Healthc; 1991 Jul; 21(28):8. PubMed ID: 10111839
    [No Abstract]   [Full Text] [Related]  

  • 13. A discussion of pharmaceutical industry practices viewed as illegal by the federal government.
    Nino K
    Health Care Law Mon; 1999 Nov; ():8-16. PubMed ID: 11067433
    [No Abstract]   [Full Text] [Related]  

  • 14. Medicare and state health care programs; fraud and abuse: OIG civil money penalties under the Medicare prescription drug discount card program. Interim final rule with comment period.
    Office of Inspector General (OIG), HHS
    Fed Regist; 2004 May; 69(97):28842-6. PubMed ID: 15151115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCFA: PROs should probe billing fraud.
    Gardner J
    Mod Healthc; 1998 Nov; 28(45):2-3. PubMed ID: 10187309
    [No Abstract]   [Full Text] [Related]  

  • 16. Fraud investigations: the heat is on.
    Lundquist JW; Glaser DM
    Minn Med; 1998 Jun; 81(6):49-51. PubMed ID: 9640959
    [No Abstract]   [Full Text] [Related]  

  • 17. Fraud-buster contract slated for 1999.
    Weissenstein E
    Mod Healthc; 1998 Jun; 28(23):8. PubMed ID: 10180945
    [No Abstract]   [Full Text] [Related]  

  • 18. Fraud and abuse enforcement revs up.
    Wagner L
    Provider; 1996 Jan; 22(1):71-2. PubMed ID: 10154003
    [No Abstract]   [Full Text] [Related]  

  • 19. HCFA's fraud and abuse oversight criticized.
    Weissenstein E
    Mod Healthc; 1991 Oct; 21(40):14. PubMed ID: 10114167
    [No Abstract]   [Full Text] [Related]  

  • 20. The many shades of Medicare fraud and abuse.
    Dalton JF
    Contemp Longterm Care; 1996 Jun; 19(6):63. PubMed ID: 10158216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.